Common use of Compulsory Licenses Clause in Contracts

Compulsory Licenses. If a court or a governmental agency of competent jurisdiction requires Merck or its Sublicensee to grant a compulsory license to a Third Party with respect to Product in any country in the Territory with a royalty rate lower than the royalty rate provided by Section 8.5(a), then the royalty rate to be paid by Merck on Net Sales in that country under Section 8.5(a) shall be reduced [***].

Appears in 6 contracts

Samples: Master Collaboration and License Agreement, Master Collaboration and License Agreement, Master Collaboration and License Agreement (Moderna, Inc.)

AutoNDA by SimpleDocs

Compulsory Licenses. If a court or a governmental agency of competent jurisdiction requires Merck or its Sublicensee to grant a compulsory license is granted to a Third Party with respect to Compound or Product in any country in the Territory with a royalty rate lower than the royalty rate provided by Section 8.5(a)5.4.1, then the royalty rate to be paid by Merck on Net Sales in that country under Section 8.5(a) 5.4.1 shall be reduced [***]to the rate paid by the compulsory licensee.

Appears in 6 contracts

Samples: Exclusive Patent License and Research Collaboration Agreement, Exclusive Patent License and Research Collaboration Agreement, Exclusive License and Research Collaboration Agreement (Cocrystal Pharma, Inc.)

Compulsory Licenses. If a court or a governmental agency of competent jurisdiction requires Merck or its Sublicensee to grant a compulsory license is granted to a Third Party with respect to Product in any country in the Territory with a royalty rate lower than the royalty rate provided by Section 8.5(a)5.6.2 or 5.6.3, as applicable, and there has been a first commercial sale by or on behalf of said Third Party (determined according to the same standard as set forth in Section 1.33 for the First Commercial Sale of Products) of a product, then the royalty rate to be paid by Merck on Net Sales in that country under Section 8.5(a) 5.6.2 and 5.6.3, as applicable, shall be reduced [***]to the rate paid by the compulsory licensee.

Appears in 5 contracts

Samples: Research Collaboration and Exclusive License Agreement (Ablynx NV), Research Collaboration and Exclusive License Agreement (Ablynx NV), Research Collaboration and Exclusive License Agreement (Ablynx NV)

Compulsory Licenses. If a court or a governmental agency of competent jurisdiction requires Merck or its Sublicensee to grant a compulsory license required under applicable law is granted to a Third Party with respect to Product in any country in the Territory with a royalty rate lower than the royalty rate provided by Section 8.5(a)5.13, then the royalty rate to be paid by Merck on Net Sales in that country under Section 8.5(a) 5.13 shall be reduced [***]to the rate paid by the compulsory licensee.

Appears in 4 contracts

Samples: Exclusive Research Collaboration, License and Commercialization Agreement (Vertex Pharmaceuticals Inc / Ma), Exclusive Research Collaboration, License and Commercialization Agreement (Vertex Pharmaceuticals Inc / Ma), Exclusive Research Collaboration, License and Commercialization Agreement (Vertex Pharmaceuticals Inc / Ma)

Compulsory Licenses. If a court or a governmental agency of competent jurisdiction requires Merck or its Sublicensee to grant a compulsory license Compulsory License is granted to a Third Party with respect to Product in any country in the Territory with a royalty rate lower than the royalty rate provided by Section 8.5(a)5.5.1, then the royalty rate to be paid by Merck on Net Sales in that country under Section 8.5(a) 5.5.1 shall be reduced [***]] for the period during which such Compulsory License is in effect. Merck shall use commercially reasonable efforts to oppose the granting of any such Compulsory License, and if any such Compulsory License is granted, to eliminate or limit such Compulsory License to the extent possible.

Appears in 3 contracts

Samples: Exclusive License and Research Collaboration Agreement (Metabasis Therapeutics Inc), Exclusive License and Research Collaboration Agreement (Metabasis Therapeutics Inc), Exclusive License and Research Collaboration Agreement (Metabasis Therapeutics Inc)

Compulsory Licenses. If a court or a governmental agency of competent jurisdiction requires Merck or its Sublicensee to grant a compulsory license is granted to a Third Party with respect to a Collaboration Candidate or Licensed Product in any country in the Territory with a royalty rate lower than the royalty rate provided by Section 8.5(a)7.5.1, then the royalty rate to be paid by Merck to Company on Net Sales in that country under Section 8.5(a) 7.5.1 shall be reduced to [***].

Appears in 2 contracts

Samples: Exclusive License and Research Collaboration Agreement (Artiva Biotherapeutics, Inc.), Exclusive License and Research Collaboration Agreement (Artiva Biotherapeutics, Inc.)

Compulsory Licenses. If a court or a governmental agency of competent jurisdiction requires Merck or its Sublicensee to grant a compulsory license is granted to a Third Party with respect to Licensed Product in any country in the Territory with a royalty rate lower than the royalty rate provided by Section 8.5(a)5.4.1., then the royalty rate to be paid by Merck on Net Sales in that country under Section 8.5(a) 5.4.1 shall be reduced [***]to the rate paid by the compulsory Third Party licensee.

Appears in 2 contracts

Samples: Research Collaboration and License Agreement (Intercardia Inc), Research Collaboration and License Agreement (Interneuron Pharmaceuticals Inc)

Compulsory Licenses. If a court or a governmental agency of competent jurisdiction requires Merck or its Sublicensee to grant a compulsory license is granted to a Third Party with respect to Royalty Product in any country in the Territory with a royalty rate lower than the royalty rate provided by Section 8.5(a)5.5.2 or 5.5.3, as applicable, then the royalty rate to be paid by Merck on Net Sales in that country under Section 8.5(a) 5.5.2 or 5.5.3, as applicable, shall be reduced [***]to the rate paid by the compulsory licensee.

Appears in 2 contracts

Samples: Research Collaboration, Option and Exclusive License Agreement (Ambrx Inc), Research Collaboration, Option and Exclusive License Agreement (Ambrx Inc)

Compulsory Licenses. If a court or a governmental agency of competent jurisdiction requires Merck or its Sublicensee to grant a compulsory license is granted to a Third Party with respect to Product in any country in the Territory with a royalty rate lower than the royalty rate provided by Section 8.5(a)5.3.2 or 5.3.3, as applicable, then the royalty rate to be paid by Merck on Net Sales in that country under Section 8.5(a) 5.3.2 or 5.3.3, as applicable, shall be reduced [***]to the rate paid by the compulsory licensee.

Appears in 2 contracts

Samples: Collaboration and Exclusive License Agreement (Chimerix Inc), Collaboration and Exclusive License Agreement (Chimerix Inc)

Compulsory Licenses. If a court or a governmental agency of competent jurisdiction requires Merck or its Sublicensee to grant a compulsory license is granted to a Third Party third party with respect to Product in any country in the Territory with a royalty rate lower than the royalty rate provided by Section 8.5(a)5.4.1., then the royalty rate to be paid by Merck MERCK on Net Sales in that country under Section 8.5(a) 5.4.1 shall be reduced [***]to the rate paid by the compulsory licensee.

Appears in 2 contracts

Samples: Development and License Agreement (Isis Pharmaceuticals Inc), Development and License Agreement (Isis Pharmaceuticals Inc)

Compulsory Licenses. If a court or a governmental agency of competent jurisdiction requires Merck or its Sublicensee to grant a compulsory license is granted to a Third Party with respect to Product in any country in the Territory with a royalty rate lower than the royalty rate provided by Section 8.5(a)5.4.1, then the royalty rate to be paid by Merck MERCK on Net Sales in that country under Section 8.5(a) 5.4.1 shall be reduced [***]to the rate paid by the compulsory licensee.

Appears in 2 contracts

Samples: License and Research Collaboration Agreement (Aveo Pharmaceuticals Inc), License and Research Collaboration Agreement (Aveo Pharmaceuticals Inc)

Compulsory Licenses. If a court or a governmental agency of competent jurisdiction requires Merck or its Sublicensee to grant a compulsory license is granted to a Third Party with respect to Royalty Product in any country in the Territory with a royalty rate lower than the royalty rate provided by Section 8.5(a)[ * ], then the royalty rate to be paid by Merck MERCK on Net Sales in that country under this Section 8.5(a) 4.4 shall be reduced [***[ * ].

Appears in 1 contract

Samples: Exclusive License Agreement (Exelixis Inc)

Compulsory Licenses. If a court or a governmental agency of competent jurisdiction requires Merck or its Sublicensee to grant a compulsory license is granted to a Third Party with respect to Licensed Product in any country in the Territory with a royalty rate lower than the royalty rate [**] provided by Section 8.5(a)5.4.1., then the royalty rate to be paid by Merck MERCK on Net Sales in that country under Section 8.5(a) shall be reduced 5.4.1 [***].

Appears in 1 contract

Samples: Research Collaboration and License Agreement (Nitromed Inc)

Compulsory Licenses. If a court or a governmental agency of competent jurisdiction requires Merck or its Sublicensee to grant a compulsory license is granted to a Third Party with respect to Product in any country in the Territory with a royalty rate lower than the royalty rate provided by Section 8.5(a)subsection 5.4.1, then the royalty rate to be paid by Merck on Net Sales in that country under Section 8.5(a) subsection 5.4.1 shall be reduced to [***].

Appears in 1 contract

Samples: Exclusive Development, Commercialization and License Agreement (Nastech Pharmaceutical Co Inc)

Compulsory Licenses. If a court or a governmental agency of competent jurisdiction requires Merck or its Sublicensee to grant a compulsory license is granted to a Third Party with respect to Product in any country in the Territory with a royalty rate lower than the royalty rate provided by Section 8.5(a)5.4.1, then the royalty rate to be paid by Merck on Net Sales in that country under Section 8.5(a) 5.4.1 shall be reduced [***]to the rate paid by the compulsory licensee.

Appears in 1 contract

Samples: Exclusive License and Development Collaboration Agreement (Dynavax Technologies Corp)

Compulsory Licenses. If a court MERCK or a governmental agency Related Party, as a condition of competent jurisdiction requires Merck obtaining or its Sublicensee maintaining Marketing Authorization in a country, is required to grant a compulsory license to a Third Party with respect to Product in any country in the Territory with a Territory, and the royalty rate under such compulsory license is lower than the royalty rate provided by Section 8.5(a)5.6.1, then the royalty rate to be paid by Merck MERCK on Net Sales under the applicable compulsory license in that country under Section 8.5(a) 5.6.1 shall be reduced [***]to the rate paid by the compulsory licensee.

Appears in 1 contract

Samples: Exclusive License, Development and Commercialization Agreement (Dov Pharmaceutical Inc)

Compulsory Licenses. If a court or a governmental agency of competent jurisdiction requires Merck or its Sublicensee to grant a compulsory license is granted to a Third Party with respect to Product Compounds or Products in any country in the Territory with a royalty rate lower than the royalty rate provided by Section 8.5(a)5.4.1, then the royalty rate amount to be paid by Merck on Net Sales in that country under Section 8.5(a) 5.4.1 shall be reduced [***].

Appears in 1 contract

Samples: Exclusive License and Research Collaboration Agreement (Proteostasis Therapeutics, Inc.)

Compulsory Licenses. If a court or a governmental agency of competent jurisdiction requires Merck or its Sublicensee to grant a compulsory license is granted to a Third Party with respect to Compound or Product in any country in the Territory with a royalty rate lower than the royalty rate provided by Section 8.5(a)7.4.1, then the royalty rate to be paid by Merck on Net Sales in that country under Section 8.5(a) 7.4.1 shall be reduced [***]to the rate paid by the compulsory licensee.

Appears in 1 contract

Samples: Exclusive Patent License and Research Collaboration Agreement (Sutro Biopharma Inc)

Compulsory Licenses. If a court or a governmental agency of competent jurisdiction requires Merck or its Sublicensee to grant a compulsory license to a Third Party with respect to Product in any country in the Territory with a royalty rate lower than the royalty rate provided by Section 8.5(a), then the royalty rate to be paid by Merck Xxxxx on Net Sales in that country under Section 8.5(a) shall be reduced [***].

Appears in 1 contract

Samples: Master Collaboration and License Agreement

AutoNDA by SimpleDocs

Compulsory Licenses. If a court or a governmental agency of competent jurisdiction requires Merck or its Sublicensee to grant a compulsory license is granted to a Third Party with respect to Product [**] in any country in the Territory with a royalty rate lower than the royalty rate provided by Section 8.5(a)5.5, then the royalty rate to be paid by Merck on Net Sales in that country under Section 8.5(a) 5.5 shall be reduced [***]to the rate paid by the compulsory licensee.

Appears in 1 contract

Samples: Research Collaboration and License Agreement (Decode Genetics Inc)

Compulsory Licenses. If a court or a governmental agency of competent jurisdiction requires Merck or its Sublicensee to grant a compulsory license is granted to a Third Party with respect to Product Candidate or Licensed Product in any country in the Territory with a royalty rate lower than the royalty rate provided by Section 8.5(a)5.3.1, then the royalty rate amount to be paid by Merck on Net Sales in that country under Section 8.5(a) 5.3.1 shall be reduced [***]to the amount paid by the compulsory licensee.

Appears in 1 contract

Samples: Research Collaboration and Exclusive License Agreement (Foghorn Therapeutics Inc.)

Compulsory Licenses. If a court or a governmental agency of competent jurisdiction requires Merck or its Sublicensee to grant a compulsory license required pursuant to applicable law or regulation in a country is granted to a Third Party with respect to Product in any country in the Territory with a royalty rate lower than the royalty rate provided by Section 8.5(a)5.4.1, then the royalty rate to be paid by Merck on Net Sales in that country under Section 8.5(a) 5.4.1 shall be reduced [***]to the rate paid by the compulsory licensee.

Appears in 1 contract

Samples: Exclusive License and Research Collaboration Agreement (Idera Pharmaceuticals, Inc.)

Compulsory Licenses. If a court or a governmental agency of competent jurisdiction requires Merck or its Sublicensee to grant a compulsory license is granted to a Third Party third party with respect to a Royalty Bearing Product in any country in the Territory with a royalty rate lower than the royalty rate provided by Section 8.5(a)5.4.1., then the royalty rate to be paid by Merck on Net Sales in that country under Section 8.5(a) 5.4.1 shall be reduced [***]to the rate paid by the compulsory Third Party licensee.

Appears in 1 contract

Samples: Research Collaboration and License Agreement (Isis Pharmaceuticals Inc)

Compulsory Licenses. If a court or a governmental agency of competent jurisdiction requires Merck or its Sublicensee to grant a compulsory license is granted to a Third Party with respect to any Product in any country in the Territory with a royalty rate lower than the royalty rate provided by Section 8.5(a)5.7, then the royalty rate to be paid by Merck on Net Sales in that country under Section 8.5(a) 5.7 shall be reduced [***]to the rate paid by the compulsory licensee.

Appears in 1 contract

Samples: Collaboration and License Agreement (Foxhollow Technologies, Inc.)

Compulsory Licenses. If a court or a governmental agency of competent jurisdiction requires Merck or its Sublicensee to grant a compulsory license is granted to a Third Party with respect to Royalty Product in any country in the Territory with a royalty rate lower than the royalty rate provided by Section 8.5(a9.6.1(a) or Section 9.6.1(b), as applicable, then the royalty rate to be paid by Merck on Net Sales in that country under Section 8.5(a9.6.1(a) or Section 9.6.1(b) shall be reduced [***]to the rate paid by the compulsory licensee.

Appears in 1 contract

Samples: Research Collaboration, Product Development and License Agreement (NGM Biopharmaceuticals Inc)

Compulsory Licenses. If a court or a governmental agency of competent jurisdiction requires Merck or its Sublicensee to grant a compulsory license Compulsory License is granted to a Third Party with respect to Product in any country in the Territory with a royalty rate lower than the royalty rate provided by Section 8.5(a)5.4, then the royalty rate to be paid by Merck on Net Sales in that country under Section 8.5(a) 5.4 shall be reduced [***]] for the period during which such Compulsory License is in effect. Merck shall use commercially reasonable efforts to oppose the granting of any such Compulsory License, and if any such Compulsory License is granted, to eliminate or limit such Compulsory License to the extent possible.

Appears in 1 contract

Samples: License and Collaboration Agreement (Metabasis Therapeutics Inc)

Compulsory Licenses. If a court or a governmental agency of competent jurisdiction requires Merck or its Sublicensee to grant a compulsory license is granted to a Third Party with respect to Product Candidate or Product in any country in the Territory with a royalty rate amount lower than the royalty rate amount provided by Section 8.5(a5.2.3(a), then then, following the First Commercial Sale of Competitive Product in such country under such compulsory license, the royalty rate amount to be paid by Merck on Net Sales in that country under Section 8.5(a5.2.3(a) shall be reduced [***]to the amount paid by the compulsory licensee during the term of such compulsory license.

Appears in 1 contract

Samples: Research Collaboration and Option to License Agreement (Armata Pharmaceuticals, Inc.)

Compulsory Licenses. If a court or a governmental agency of competent jurisdiction requires Merck or its Sublicensee to grant a compulsory license is granted to a Third Party with respect to Product in any country in the Royalty Territory with a royalty rate lower than the royalty rate provided by Section 8.5(a)9.4.1, then the royalty rate to be paid by Merck on Net Sales in that country under Section 8.5(a) 9.4.1 shall be reduced [***[ * ].

Appears in 1 contract

Samples: Collaboration, Exclusive License and Companion Diagnostic Agreement (Endocyte Inc)

Compulsory Licenses. If a court or a governmental agency of competent jurisdiction requires Merck or its Sublicensee to grant a compulsory license is granted to a Third Party with respect to Vaccine or Product in any country in the Territory with a royalty rate lower than the royalty rate provided *** by Section 8.5(a)5.3.1, then the royalty rate to be paid by Merck on Net Sales by or to such Third Party in that country under Section 8.5(a) 5.3.1 shall be reduced [***].

Appears in 1 contract

Samples: License and Research Collaboration Agreement (Opko Health, Inc.)

Compulsory Licenses. If a court or a governmental agency of competent jurisdiction requires Merck or its Sublicensee to grant a compulsory license is granted to a an independent Third Party with respect to Product in any country in the Territory with a royalty rate lower than the royalty rate provided by Section 8.5(a)5.4.1, then the royalty rate to be paid by Merck on Net Sales in that country under Section 8.5(a) 5.4.1 shall be reduced [***].

Appears in 1 contract

Samples: Research Collaboration and License Agreement (Bionomics Limited/Fi)

Compulsory Licenses. If a court or a governmental agency of competent jurisdiction requires Merck or its Sublicensee to grant a compulsory license is granted to a Third Party with respect to any Product in any country in the Territory with a royalty rate lower than the royalty rate provided by Section 8.5(a)5.11, then the royalty rate to be paid by Merck on Net Sales in that country under Section 8.5(a) 5.11 shall be reduced [***]to the rate paid by the compulsory licensee.

Appears in 1 contract

Samples: Collaboration and License Agreement (Foxhollow Technologies, Inc.)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!